Liezl Gambe

GenusPlus Group (ASX:GNP) secured a design and construct contract valued at approximately $135 million from Atmos Renewables.

Oruka Therapeutics (NASDAQ:ORKA) reported positive Week 28 results from the Phase 2a EVERLAST-A trial evaluating ORKA-001 in patients with moderate-to-severe plaque psoriasis.

HUHUTECH (NASDAQ:HUHU) reported first-half 2026 revenue of $10.67 million, an increase of 8.6% from the prior-year period, supported by contributions from new international operations.

General Mills (NYSE:GIS) reported first-quarter fiscal 2027 net sales of $4.4 billion, down 3% from the prior year due mainly to the impact of the U.S. yogurt business divestiture.

Target Corporation (NYSE:TGT) declared a regular quarterly dividend of $1.16 per common share, payable on December 1, 2026.

Oil prices fell on Wednesday after U.S. President Donald Trump said U.S. and Iranian representatives held discussions at the United Nations.

US Treasury Secretary Scott Bessent has emerged as a leading contender to serve as the new artificial intelligence coordinator for the federal government, according to an exclusive report by Semafor.

ASX (ASX:ASX) is still falling short of regulatory expectations in governance, operational resilience, and risk management, according to the latest assessment by the Reserve Bank of Australia.

Prescient Therapeutics (ASX:PTX) completed a $6 million capital raise to advance the clinical development of its target cancer therapy.

CME Group Inc (NASDAQ:CME) has expanded its digital asset derivatives suite by announcing the launch of Bitcoin Cash (BCH) and Uniswap (UNI) futures scheduled for October 19.